InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: crazy horse 0 post# 77753

Sunday, 08/08/2021 2:00:22 PM

Sunday, August 08, 2021 2:00:22 PM

Post# of 118366
Great Article: Biotechs In Cancer Research Being Acquired at Massive Valuations!

https://www.prnewswire.com/news-releases/biotech-companies-focused-on-cancer-research-are-being-acquired-at-massive-valuations-300961695.html

Yes, that's quite correct, and this will likely happen to RGBP which I recently predicted an 80% probability.

One major example of that is Kite Pharma being acquired by Gilead Sciences in 2017 for $11.9 Billion to control their only Patent based on mRNA Biotechnology for treating various cancers.

Gilead paid a premium on top of Kite Pharma's Share price for many multiples MORE than it was trading for at the time of acquisition, AND their Patent had NOT yet been approved by the FDA for clinical trials.

Just goes to show you where we are today in RGBP that also has mRNA biotechnology and is in the same cancer treatment space as Kite.

Be well and prosper...